SCHEMBL16062804

CCC1O[C@H](OC2[C@@H](O[C@@H]3C(OCc4ccccc4)[C@H](OCCCC(=O)OC)OC(CO[C@H]4OC(CO[C@H]5OC(CC)[C@@H](C)[C@H](C)C5O[C@H]5OC(CC)[C@@H](C)[C@H](C)C5OC(=O)c5ccccc5)[C@@H](C)[C@H](C)C4OC(=O)c4ccccc4)[C@H]3C)OC(CC)[C@@H](C)[C@@H]2C)C(OC(=O)c2ccccc2)[C@@H](C)[C@@H]1C

nearest known ligand 0.38

Predicted protein targets (top 17)

	gene	UniProt	supporting neighbours	confidence
▸	NT5E	P21589	1/20	0.38

▸	SSTR2	P30874	3/20	0.35

▸	SSTR3	P32745	3/20	0.35

▸	SSTR5	P35346	3/20	0.35

▸	SSTR1	P30872	1/20	0.35

▸	SSTR4	P31391	1/20	0.35

▸	FGF2	P09038	3/20	0.35

▸	MDK	P21741	1/20	0.35

▸	FGF1	P05230	2/20	0.35

▸	VEGFA	P15692	2/20	0.35

▸	HPSE	Q9Y251	2/20	0.35

▸	PTPN1	P18031	3/20	0.35

▸	TACR1	P25103	2/20	0.35

▸	PTPN2	P17706	1/20	0.34

▸	SELP	P16109	3/20	0.34

▸	TNF	P01375	1/20	0.34

▸	MCHR1	Q99705	2/20	0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL16062805	0.97	NT5E (0.36)	NT5ESSTR2SSTR3SSTR5SSTR1
SCHEMBL16062802	0.96	SELP (0.38)	NT5ESSTR2SSTR3SSTR5SSTR1
SCHEMBL16062807	0.96	NT5E (0.36)	NT5ESSTR2SSTR3SSTR5SSTR1
SCHEMBL16062803	0.94	NT5E (0.36)	NT5ESSTR2SSTR3SSTR5SSTR1
SCHEMBL16062799	0.94	NT5E (0.39)	NT5ESSTR2SSTR3SSTR5SSTR1
SCHEMBL16849996	0.86	LMNA (0.40)	NT5ESSTR2SSTR3SSTR5SSTR1
SCHEMBL16062800	0.85	LGALS8 (0.41)	NT5ESSTR2SSTR3SSTR5TACR1
SCHEMBL16062810	0.84	TACR1 (0.36)	SSTR2SSTR3SSTR5SSTR1SSTR4
SCHEMBL16062797	0.83	KDM4E (0.39)	SSTR2SSTR3SSTR5SSTR1SSTR4
SCHEMBL4407362	0.82	FGF2 (0.40)	NT5EFGF2MDKFGF1VEGFA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20180002365-A1	OLIGOSACCHARIDE-PROTEIN CONJUGATES	GENZYME CORPORATION	2018-01-04	—	—	US	disclosed
US-9493498-B2	Oligosaccharide-protein conjugates	GENZYME CORPORATION (US)	2016-11-15	—	—	US	disclosed
US-20150175643-A1	OLIGOSACCHARIDE-PROTEIN CONJUGATES	GENZYME CORPORATION	2015-06-25	—	—	US	disclosed
US-8835614-B2	Oligosaccharide-protein conjugates	GENZYME CORPORATION (US)	2014-09-16	—	—	US	disclosed
US-20110300120-A1	OLIGOSACCHARIDE-PROTEIN CONJUGATES	GENZYME CORPORATION	2011-12-08	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20110300120-A1	OLIGOSACCHARIDE-PROTEIN CONJUGATES	MAN2B1, GAA, GBA1	NT5E 2722/4885SSTR2 2748/4885SSTR3 2234/4885
US-20150175643-A1	OLIGOSACCHARIDE-PROTEIN CONJUGATES	MAN2B1, GAA, GBA1	NT5E 2722/4885SSTR2 2748/4885SSTR3 2234/4885
US-20180002365-A1	OLIGOSACCHARIDE-PROTEIN CONJUGATES	MAN2B1, GAA, GBA1	NT5E 2722/4885SSTR2 2748/4885SSTR3 2234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.